Posted on 12/13/2004 6:20:45 PM PST by ddtorque
Multiple sclerosis (MS) affects some 400,000 Americans and is the most common neurological disorder diagnosed in young adults. MS affects eyesight, mobility, bladder and bowel control, and causes chronic pain and dizziness.
A quarter of those diagnosed with MS may actually have a benign form, meaning they won't have any symptoms for at least 10 years. Currently, however, there is no method of determining who has this benign form. The result: Many people, diagnosed with MS, are taking medication they don't yet need, with all the attendant side-effects, as well as suffering from excessive anxiety. There is also no way to determine who has the most severe form of the disease - approximately 20 percent of MS sufferers. If this could be diagnosed at the outset, these people could get the most aggressive treatment available.
Now, an Israeli company, Glycominds, has a simple blood test that could solve this problem by distinguishing between mild and more severe cases of MS early on. Clinical trials of the new test are about to begin across the US and Canada.
(Excerpt) Read more at israel21c.org ...
Thanks for posting this. My son has a seemingly mild form of MS. His mother died with it, so this is particularly interesting to my family.
Must be some sort of embargo on press re: pharmaceutical, scientific and medical breakthroughs originating the the Arab and Islamic world - because I never read about them.
ping
There's a movement to divest from Israel going on.
bttt
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.